Albutoin

Albutoin
Clinical data
Other names	BAX-422Z[1]
Identifiers
	IUPAC name 3-Allyl-5-isobutyl-2-thioxo-4-imidazolidinone;
CAS Number	830-89-7;
PubChem CID	3032361;
ChemSpider	2297355;
Chemical and physical data
Formula	C10H16N2OS
Molar mass	212.31 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES S=C1N(C(=O)C(N1)CC(C)C)C\C=C;

Albutoin is an anticonvulsant.[1][2] It was marketed in Europe as CO-ORD and Euprax by Baxter Laboratories.[1] It was evaluated by the United States Food and Drug Administration, but not approved.[3]

References

J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 24–. ISBN 978-1-4757-2085-3.
Cereghino, J. J.; Brock, J. T.; Van Meter, J. C.; Penry, J. K.; Smith, L. D.; Fisher, P; Ellenberg, J (1974). "Evaluation of albutoin as an antiepileptic drug". Clinical Pharmacology and Therapeutics. 15 (4): 406–16. doi:10.1002/cpt1974154406. PMID 4206927.
Shorvon, Simon D. (2009). "Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959-2009". Epilepsia. 50: 93–130. doi:10.1111/j.1528-1167.2009.02042.x. PMID 19298435.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.